Charlotte N Stahlfeld Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2023	Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer.
11/2022	A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer.
1/2022	Reversible epigenetic alterations regulate class I HLA loss in prostate cancer.
11/2021	AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer.
10/2021	Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.
1/2020	Pairing Microwell Arrays with an Affordable, Semiautomated Single-Cell Aspirator for the Interrogation of Circulating Tumor Cell Heterogeneity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charlotte N Stahlfeld Research Topics

Disease

6	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2020
4	Circulating Neoplastic Cells 01/2023 - 10/2021
3	Neoplasms (Cancer) 01/2023 - 01/2022
1	Adenocarcinoma 11/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021

Drug/Important Bio-Agent (IBA)

4	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 10/2021
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Epithelial Cell Adhesion MoleculeIBA 01/2023
1	Surface Antigens (Surface Antigen)IBA 01/2023
1	Complementary DNA (cDNA)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	MethyltransferasesIBA 01/2022
1	ChromatinIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	abirateroneIBA 10/2021
1	enzalutamideIBA 10/2021

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2021
4	Castration 01/2023 - 01/2020